Incorrect blister count after artwork change – packaging vs equipment root cause


Published on 15/01/2026

Addressing Incorrect Blister Count Issues Following Artwork Changes in Packaging

In pharmaceutical manufacturing, leveraging accurate blister packaging is critical for compliance and product integrity. A misalignment in blister counts after an artwork change can lead to significant quality control issues and regulatory scrutiny. This article provides a structured approach to troubleshooting this complex problem, empowering you to implement effective containment measures, execute a thorough investigation, and develop robust corrective and preventive actions (CAPA).

For a broader overview and preventive tips, explore our Blister & Cartoning Machine Issues.

By the end of this guide, you will have a clear understanding of how to identify the symptoms associated with incorrect blister counts, explore their causes, and implement solutions that meet GMP standards while maintaining inspection readiness.

Symptoms/Signals on the Floor or in the Lab

The initial signs of incorrect blister counts can manifest through various symptoms during production. Identifying these

early can mitigate more significant issues later. Key symptoms include:

  • Frequent dosing discrepancies: Tablets or capsules coming out in numbers that differ from labeled quantities.
  • Increased scrap rates: High levels of reject product due to identification of miscounted blisters during inspection.
  • Feedback from QC: Quality control teams reporting anomalies in blister counts from batch records.
  • Operator observations: Equipment operators noting irregular behaviors during the packing process, such as jams or unexpected stops.

Documenting these signals accurately is vital, as they form the basis for initial investigations and assessments. Always ensure that operators are trained to document any irregularities without delay, as timely interventions can prevent production batch issues.

Likely Causes

Understanding the reasons behind incorrect blister counts is essential for effective problem resolution. The analysis of potential causes can be categorized into six areas: Materials, Method, Machine, Man, Measurement, and Environment (the 6 M’s).

1. Materials

  • Incorrect specifications of the blister material or incorrect batch of product leading to misalignment with the artwork.
  • Quality issues in the active pharmaceutical ingredient (API) or excipients affecting overall counts.

2. Method

  • Changes in the operating procedure for blister pack assembly that have not been updated post-artwork change.
  • Lack of process validation for new artwork leading to discrepancies in expected outputs.
Pharma Tip:  Incorrect blister count during blister packing – packaging vs equipment root cause

3. Machine

  • Faults in blister packing equipment, such as misaligned sensors or incorrect programming parameters.
  • Regular wear of machine components resulting in inaccurate counts, particularly if setup adjustments were required for the new artwork.

4. Man

  • Insufficient training of personnel managing the equipment or lacking familiarity with changes introduced by artwork updates.
  • Human error in setting parameters or monitoring during the transition to new packaging.

5. Measurement

  • Inefficiencies in measurement techniques for counting blisters, leading to missed discrepancies in counts.
  • Improper calibration of counting systems or sensors attached to the blister machine.

6. Environment

  • Changes in environmental conditions in the production area that affect equipment performance (e.g., humidity affecting adhesives).
  • Inadequate cleaning of the machinery potentially leading to blockages or incorrect counts.

Immediate Containment Actions

Once a potential issue with blister counts has been identified, immediate containment actions are necessary to protect product quality and reduce risks. Within the first 60 minutes:

  • Halt production: Stop the blister packaging process to prevent further distribution of potentially non-compliant products.
  • Notify QC: Alert the quality control team for immediate assessment and assistance. This may necessitate isolating affected batches.
  • Document the incident: Record all relevant details including timestamp, product details, observed discrepancies, and affected production areas.
  • Conduct a preliminary review: Review recently implemented changes in artwork or machine setup that could have contributed to the issue.

By implementing these quick actions, you minimize the risk of distributing non-compliant products and create an evidence trail for investigation.

Investigation Workflow

Following containment, a robust investigation is crucial to determine the underlying issues causing incorrect blister counts. This investigation should be methodical and data-driven:

  • Data collection: Gather batch records, equipment logs, operator notes, and any related deviation reports. Ensure that counts from the manual inspection process exceed automated counts for cross-validation.
  • Data interpretation: Analyze data to detect patterns, such as whether the issue arises primarily in specific batches, with certain operators, or during specific operational times.

Involving cross-functional teams can yield diverse perspectives, enhancing the quality of the investigation. Regular updates should be provided to stakeholders, ensuring transparency regarding the status of the inquiry.

Root Cause Tools

Once data has been collated, utilizing structured root cause analysis tools can facilitate deeper investigations:

5-Why Analysis

This technique involves asking “Why?” repeatedly (typically five times) until the fundamental cause of the issue is identified. It’s simple yet effective for straightforward problems.

Fishbone Diagram

This method categorizes potential causes under major headings (e.g., Method, Machine, Man), allowing for visual representation of complex interrelations. Suitable for multifaceted issues such as misunderstandings around hardware upgrades.

Pharma Tip:  Machine synchronization error during inspection – packaging vs equipment root cause

Fault Tree Analysis

For more complicated failures, this tool helps identify various paths that can lead to the issue, detailing potential failures systematically. Ideal for technical issues with equipment.

Select the appropriate root cause analysis tool based on the complexities observed during the assessment phase, focusing on constitutional weaknesses in your processes or systems that could generate future incidents.

CAPA Strategy

Once the root cause has been determined, formulate a CAPA strategy to address and prevent recurrence:

  • Correction: Implement immediate corrections to address the detected issue. This may include recalibrating equipment or re-training personnel.
  • Corrective Action: Beyond fixing the immediate issue, establish actions that systematically eliminate the identified root cause, such as revising operating procedures.
  • Preventive Action: Assess the broader implications of the investigation findings. Institute preventive measures such as enhanced training programs and regular audits to avert similar issues in the future.

Control Strategy & Monitoring

Post-CAPA implementation, establish an ongoing control strategy to monitor the effectiveness of changes and maintain compliance:

Related Reads

  • Statistical Process Control (SPC): Employ SPC techniques to monitor blister counting operations and detect shifts in process control metrics.
  • Trend analysis: Review data trends periodically to identify any emerging non-conformance patterns that may indicate further issues.
  • Sampling: Conduct regular sampling of produced blisters to verify the accuracy of counts against established standards.
  • Alarm Systems: Implement alarms for immediate notification when count thresholds are exceeded, enabling rapid response to potential new failures.
  • Verification: Regularly audit the counting systems and equipment setups to ensure ongoing compliance with specifications.

Validation / Re-qualification / Change Control Impact

Changes arising from the investigation could necessitate re-validation of processes or equipment:

  • If equipment settings have been modified significantly or if there has been a change in blister materials, a re-validation exercise should be conducted to confirm that output meets required specifications.
  • Document all changes formally through change control processes to promote transparency and traceability.

Assessing the need for re-qualification is critical, especially in regulated environments where compliance with GMP is paramount.

Inspection Readiness: What Evidence to Show

To ensure inspection readiness following adjustments, maintain comprehensive records that demonstrate compliance and problem resolution:

  • Records: Ensure clear documentation of all actions taken during the incident including communication with personnel, timelines, and summaries of meetings.
  • Batch Documentation: Maintain values from batch production records in a manner that allows easy retrieval during audits.
  • Deviations: Catalog all deviation reports associated with the incident, showcasing learnings taken from the issues identified.
Pharma Tip:  Machine synchronization error after artwork change – CAPA breakdown

Preparedness not only satisfies regulatory bodies but reinforces internal quality control mechanisms, fostering a culture of constant improvement.

FAQs

What are the first steps when noticing incorrect blister counts?

The first steps are to halt production, notify quality control, and document all observations and discrepancies.

How can I identify the root cause of the problem?

Utilize tools such as the 5-Why technique, Fishbone diagrams, or Fault Tree Analysis to systematically evaluate potential causes.

What immediate actions should be taken to contain the situation?

Immediate actions include halting production, documenting incidents, and reviewing recent procedural changes.

How do CAPA actions differ from immediate corrections?

CAPA actions address underlying root causes and prevent future issues, while immediate corrections resolve the current problem.

What types of monitoring strategies can I use to prevent future discrepancies?

Implement statistical process control techniques, conduct regular trend analyses, and utilize sampling protocols and alarm systems for continuous monitoring.

Is re-validation necessary after a machine failure?

Yes, if significant changes were made to the process or equipment settings, re-validation may be necessary to ensure compliance with GMP.

What documentation is essential for inspection readiness?

Maintain records of all modifications, batch documentation, and deviation reports to ensure transparency and compliance during inspections.

How often should team training occur regarding equipment changes?

Team training should occur whenever significant equipment changes are made, supplemented with regular refresher courses to keep team members updated.

What role does environmental control play in blister count accuracy?

Environmental control is crucial; fluctuations in conditions like temperature and humidity can affect materials and machinery, leading to discrepancies.

Can faulty materials play a role in incorrect blister counts?

Absolutely, using inferior or incorrect materials can cause failures in the blister pack that directly lead to incorrect counts.

What should I do if discrepancies persist even after corrective measures?

If discrepancies continue, revisit your root cause analysis, assess any additional contributing factors, and refine your CAPA strategies based on new insights.

Should I involve cross-functional teams in the investigation?

Yes, including cross-functional experts brings diverse perspectives that can uncover underlying issues and enhance the effectiveness of solutions.